Menu

Japanese Authorities Recommend Not Regulating Gene Editing

Unlike judges in the European Union, a government panel in Japan says transgenic modification and genome editing are not the same.

Aug 22, 2018
Kerry Grens

ABOVE: © ISTOCK, VISUALSPACE

A Japanese government panel announced Monday (August 20) that it recommends regulating only genetically modified organisms that have had foreign genes permanently introduced into their genomes and not those whose endogenous genes have been edited, according to NHK World-Japan. This means that developers will not have to get approval from the government to produce gene-edited organisms, The Mainichi reports.

The only stipulation is that researchers and businesses will have to register their modifications to plants or animals with the government, with the exception of microbes cultured in contained environments. “We judged that there needed to be some kind of management system in place to earn consumers’ trust,” a panel member tells The Mainichi.

See “The Unregulation of Biotech Crops

Reactions to the decision are mixed. A representative from the Japan Bioindustry Association expressed support to NHK for the recommendation. While lauding the potential benefits of genome editing, an editorial in The Asahi Shimbun opposes across-the-board permission. “Since it is a new technique, there is no ruling out unforeseen risks in gene editing,” it reads. “There have actually been reports on unintended mutations as a result of gene editing.”

The newspaper recommends following the lead of the European Court of Justice, which last month decided that genetically modified products must go through the same safety and labeling processes regardless of method.

See “No Regulatory Exemption for Gene-Edited Products in EU

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.